Global Research on Antimicrobial Resistance (GRAM)

Global Research on Antimicrobial Resistance (GRAM) is the flagship project of the Oxford GBD (Global Burden of Disease) Group, and aims to provide robust, comprehensive and timely evidence of the burden of antimicrobial resistance (AMR) globally.

There is currently very little data on the incidence, prevalence or burden of AMR in low- and middle-income countries (LMICs), which limits our understanding of the impact that AMR is having on human and animal health, and inhibits the development and targeting of appropriate interventions.

The overall aim is to strengthen the evidence base on the current global burden of AMR, and how, where and why it is changing. This will provide the essential health intelligence to help drive awareness, support better surveillance, and prompt policy action to control AMR, including facilitating antimicrobial stewardship.

University of Oxford’s Big Data Institute and the Institute for Health Metrics and Evaluation

Wellcome Trust and The Bill and Melinda Gates Foundation

June 2016 - June 2021